SEC Form 4 · accession 0001209191-15-028572
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Lindemoen
Officer — SVP Sales and Client Services
Period of report
Mar 19, 2015
Accepted (ET)
Mar 23, 2015 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Mar 19, 2015 | A | 4,794 | $0.00 | A | 26,284 | D | |
| Common Stock, $0.01 par value | Mar 19, 2015 | A | 5,274 | $0.00 | A | 31,558 | D | |
| Common Stock, $0.01 par value | Mar 19, 2015 | F | 1,701 | $27.85 | D | 29,857 | D |
Table II — derivative securities
No Table II lines on this filing.